Home / Healthcare / Pharmaceutical / Biosimilars Market

Biosimilars Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Filgrastim & Peg-filgrastim, Monoclonal Antibodies, and Others), By Disease Indication (Cancer, Autoimmune Diseases {Arthritis, Psoriasis, and Others}, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

Report Format: PDF | Latest Update: Jul, 2024 | Published Date: Jan, 2024 | Report ID: FBI108928 | Status : Published
  • Global
  • 2022
  • 150
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Buy Now

Healthcare Clients